Medication pricing
Transparent starter-plan and dose pricing for currently available prescription treatments. Every medicine still requires an independent clinical review and prescription from a licensed specialist.
Tirzepatide injection · GIP and GLP-1 receptor agonist
A once-weekly dual-action treatment. Starter plans begin at 2.5 mg and move only when the prescribing specialist confirms the next dose.
Starter plans
The displayed ladder is what the plan includes. Your actual prescription may stay at a lower dose or follow a different pace.
3-month starter
Most selected6-month starter
9-month starter
12-month starter
The listed monthly dose ladder is included; the specialist may prescribe a lower dose or different pace.
Dose reference
Useful when a specialist prescribes a different dose or a higher-dose upgrade.
Tirzepatide commonly starts at 2.5 mg. Any increase depends on the prescribing specialist’s review and the patient’s tolerance.
Safety and billing
Eligibility, medicine, dose, and treatment pace are decided independently by the treating specialist after reviewing contraindications, history, and current medication.
An approved prescription is fulfilled by a licensed pharmacy partner. Zelta does not manufacture, store, or dispense medication.
One-time payment. No automatic renewal. Processed charges may remain non-refundable. Medication already processed for shipment or dispatched may be non-cancellable and non-refundable under the applicable policies.
Not sure which option fits?
Plan offers and manufacturer MRPs shown are from Zelta’s current September 2026 catalogue and may change before payment if manufacturer or supply pricing changes. The confirmed payable amount is always shown before payment.